Yarrow Bioscience, Inc. (YARW) stock
YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)
Close on Nov 17, 2026Market cap $37.94MP/E –Yield –
Yarrow Bioscience profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Yarrow Bioscience's profit margin for the twelve months ending Jun 30, 2025 was -8097.7%. For fiscal 2025 it was -4646.1%, against -7950.9% the year before. The highest annual figure on record is -634.6% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4646.1% | +3304.8 |
| FY2024 | Dec 31, 2024 | -7950.9% | −1240.5 |
| FY2023 | Dec 31, 2023 | -6710.4% | −1844.5 |
| FY2022 | Dec 31, 2022 | -4865.8% | +3010.5 |
| FY2021 | Dec 31, 2021 | -7876.4% | −6659.0 |
| FY2020 | Dec 31, 2020 | -1217.4% | +20267.5 |
| FY2019 | Dec 31, 2019 | -21484.9% | −19421.9 |
| FY2018 | Dec 31, 2018 | -2062.9% | −1428.4 |
| FY2017 | Dec 31, 2017 | -634.6% | +1452.7 |
| FY2016 | Dec 31, 2016 | -2087.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -3100.0% | +11211.9 |
| Q1 FY2026 | Mar 31, 2026 | -4168.6% | +5878.5 |
| Q2 FY2025 | Jun 30, 2025 | -8340.6% | −3590.1 |
| Q1 FY2025 | Mar 31, 2025 | -4262.9% | +2113.7 |
| Q4 FY2024 | Dec 31, 2024 | -14311.9% | −6169.8 |
| Q3 FY2024 | Sep 30, 2024 | -10047.1% | −4271.7 |
| Q2 FY2024 | Jun 30, 2024 | -4750.5% | +2699.9 |
| Q1 FY2024 | Mar 31, 2024 | -6376.5% | −697.7 |
| Q4 FY2023 | Dec 31, 2023 | -8142.1% | +157607.9 |
| Q3 FY2023 | Sep 30, 2023 | -5775.4% | −111.4 |
| Q2 FY2023 | Jun 30, 2023 | -7450.4% | −723.4 |
| Q1 FY2023 | Mar 31, 2023 | -5678.8% | −8302.4 |
| Q4 FY2022 | Dec 31, 2022 | -165750.0% | −161511.9 |
| Q3 FY2022 | Sep 30, 2022 | -5664.1% | +10339.7 |
| Q2 FY2022 | Jun 30, 2022 | -6727.0% | +26.9 |
| Q1 FY2022 | Mar 31, 2022 | 2623.6% | +11558.4 |
| Q4 FY2021 | Dec 31, 2021 | -4238.1% | −3697.2 |
| Q3 FY2021 | Sep 30, 2021 | -16003.8% | −15247.7 |
| Q2 FY2021 | Jun 30, 2021 | -6753.9% | −5321.3 |
| Q1 FY2021 | Mar 31, 2021 | -8934.8% | −6635.8 |
| Q4 FY2020 | Dec 31, 2020 | -540.9% | +15383.6 |
| Q3 FY2020 | Sep 30, 2020 | -756.0% | +4180.4 |
| Q2 FY2020 | Jun 30, 2020 | -1432.6% | −1350.3 |
| Q1 FY2020 | Mar 31, 2020 | -2299.0% | +247.7 |
| Q4 FY2019 | Dec 31, 2019 | -15924.4% | −15590.1 |
| Q1 FY2019 | Mar 31, 2019 | -4936.4% | −4037.4 |
| Q2 FY2018 | Jun 30, 2018 | -82.3% | +1288.1 |
| Q1 FY2018 | Mar 31, 2018 | -2546.7% | −1327.5 |
| Q4 FY2017 | Dec 31, 2017 | -334.3% | – |
| Q3 FY2017 | Sep 30, 2017 | -899.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -1370.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -1219.2% | – |
See a number that looks wrong?